title: Drug development for chronic cancers: time to think differently?
authors.forename: David R
authors.initials: DR
authors.lastname: Spriggs
mesh_terms: D000077216:Carcinoma, Ovarian Epithelial; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D034261:Epothilones / Q000627:therapeutic use*; D005185:Fallopian Tube Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*
chemical_list: D034261:Epothilones; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin; C093788:epothilone B